The Role of TLR4 in the Paclitaxel Effects on Neuronal Growth In Vitro

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Ustinova, Elena E ^a   Shurin, Galina V ^a   Gutkin, Dmitriy W ^a   Shurin, Michael R ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; PACLITAXEL; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ARTICLE; CELL STRUCTURE; CELL VIABILITY; CELLULAR PARAMETERS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG CYTOTOXICITY; DRUG EFFECT; IN VITRO STUDY; MOUSE; NERVE CELL GROWTH; NERVE FIBER GROWTH; NEURITE; NEURITE LENGTH; NEUROTOXICITY; NONHUMAN; SPINAL GANGLION; WILD TYPE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, KNOCKOUT; NEURONS; PACLITAXEL; TOLL-LIKE RECEPTOR 4;

EID: 84874148515     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056886     Document Type: Article

References (47)

1. Goldspiel BR, (1997) Clinical overview of the taxanes. Pharmacotherapy 17: 110S-125S.
2. Crown J, O'Leary M, (2000) The taxanes: an update. Lancet 355: 1176-1178.
3. Mekhail TM, Markman M, (2002) Paclitaxel in cancer therapy. Expert Opin Pharmacother 3: 755-766.
4. Xiao H, Verdier-Pinard P, Fernandez-Fuentes N, Burd B, Angeletti R, et al. (2006) Insights into the mechanism of microtubule stabilization by Taxol. Proc Natl Acad Sci U S A 103: 10166-10173.
5. Kawasaki K, Akashi S, Shimazu R, Yoshida T, Miyake K, et al. (2001) Involvement of TLR4/MD-2 complex in species-specific lipopolysaccharide-mimetic signal transduction by Taxol. J Endotoxin Res 7: 232-236.
6. Tichomirowa MA, Theodoropoulou M, Daly AF, Yassouridis A, Hansen S, et al. (2008) Toll-like receptor-4 is expressed in meningiomas and mediates the antiproliferative action of paclitaxel. Int J Cancer 123: 1956-1963.
7. Barajon I, Serrao G, Arnaboldi F, Opizzi E, Ripamonti G, et al. (2009) Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system and dorsal root ganglia. J Histochem Cytochem 57: 1013-1023.
8. Nowicki M, Muller K, Serke H, Kosacka J, Vilser C, et al. (2010) Oxidized low-density lipoprotein (oxLDL)-induced cell death in dorsal root ganglion cell cultures depends not on the lectin-like oxLDL receptor-1 but on the toll-like receptor-4. J Neurosci Res 88: 403-412.
9. van Noort JM, Bsibsi M, (2009) Toll-like receptors in the CNS: implications for neurodegeneration and repair. Prog Brain Res 175: 139-148.
10. Rolls A, Shechter R, London A, Ziv Y, Ronen A, et al. (2007) Toll-like receptors modulate adult hippocampal neurogenesis. Nat Cell Biol 9: 1081-1088.
11. Tahara K, Kim HD, Jin JJ, Maxwell JA, Li L, et al. (2006) Role of toll-like receptor signalling in Abeta uptake and clearance. Brain 129: 3006-3019.
12. Jin JJ, Kim HD, Maxwell JA, Li L, Fukuchi K, (2008) Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease. J Neuroinflammation 5: 23.
13. Hagiwara H, Sunada Y, (2004) Mechanism of taxane neurotoxicity. Breast Cancer 11: 82-85.
14. Park SB, Lin CS, Krishnan AV, Friedlander ML, Lewis CR, et al. (2011) Early, progressive, and sustained dysfunction of sensory axons underlies paclitaxel-induced neuropathy. Muscle Nerve 43: 367-374.
15. Scripture CD, Figg WD, Sparreboom A, (2006) Peripheral neuropathy induced by paclitaxel: recent insights and future perspectives. Curr Neuropharmacol 4: 165-172.
16. Peters CM, Jimenez-Andrade JM, Jonas BM, Sevcik MA, Koewler NJ, et al. (2007) Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells. Exp Neurol 203: 42-54.
17. Wozniak KM, Nomoto K, Lapidus RG, Wu Y, Carozzi V, et al. (2011) Comparison of neuropathy-inducing effects of eribulin mesylate, paclitaxel, and ixabepilone in mice. Cancer Res 71: 3952-3962.
18. Marupudi NI, Han JE, Li KW, Renard VM, Tyler BM, et al. (2007) Paclitaxel: a review of adverse toxicities and novel delivery strategies. Expert Opin Drug Saf 6: 609-621.
19. John J, Ismail M, Riley C, Askham J, Morgan R, et al. (2010) Differential effects of Paclitaxel on dendritic cell function. BMC Immunol 11: 14.
20. Chuang LT, Lotzova E, Heath J, Cook KR, Munkarah A, et al. (1994) Alteration of lymphocyte microtubule assembly, cytotoxicity, and activation by the anticancer drug taxol. Cancer Res 54: 1286-1291.
21. Shurin M, Naiditch H, Gutkin D, Umansky V, Shurin G, (2012) ChemoImmunoModulation: Immune Regulation by the Antineoplastic Chemotherapeutic Agents. Current Medicinal Chemistry in press.
22. Shurin GV, Tourkova IL, Kaneno R, Shurin MR, (2009) Chemotherapeutic agents in noncytotoxic concentrations increase antigen presentation by dendritic cells via an IL-12-dependent mechanism. J Immunol 183: 137-144.
23. Kaneno R, Shurin GV, Kaneno FM, Naiditch H, Luo J, et al. (2011) Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cells. Cell Oncol (Dordr) 34: 97-106.
24. Zhong H, Han B, Tourkova IL, Lokshin A, Rosenbloom A, et al. (2007) Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth. Clin Cancer Res 13: 5455-5462.
25. Michels T, Shurin G, Naiditch H, Sevko A, Umansky V, et al. (2012) Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cells in vitro in a TLR4-independent manner. J Immunotoxicol in press.
26. Sevko A, Kremer V, Falk C, Umansky L, Shurin M, et al. (2012) Application of paclitaxel in low noncytotoxic doses supports vaccination with melanoma antigens in mice. J Immunotoxicol in press.
27. Kaneno R, Shurin GV, Tourkova IL, Shurin MR, (2009) Chemomodulation of human dendritic cell function by antineoplastic agents in low noncytotoxic concentrations. J Transl Med 7: 58.
28. Naiditch H, Shurin MR, Shurin GV, (2011) Targeting myeloid regulatory cells in cancer by chemotherapeutic agents. Immunol Res 50: 276-285.
29. Malin SA, Davis BM, Molliver DC, (2007) Production of dissociated sensory neuron cultures and considerations for their use in studying neuronal function and plasticity. Nat Protoc 2: 152-160.
30. Visintin A, Halmen KA, Latz E, Monks BG, Golenbock DT, (2005) Pharmacological inhibition of endotoxin responses is achieved by targeting the TLR4 coreceptor, MD-2. J Immunol 175: 6465-6472.
31. Meijering E, Jacob M, Sarria JC, Steiner P, Hirling H, et al. (2004) Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images. Cytometry A 58: 167-176.
32. Kirikae F, Kirikae T, Qureshi N, Takayama K, Morrison DC, et al. (1995) CD14 is not involved in Rhodobacter sphaeroides diphosphoryl lipid A inhibition of tumor necrosis factor alpha and nitric oxide induction by taxol in murine macrophages. Infect Immun 63: 486-497.
33. Wang J, Kobayashi M, Han M, Choi S, Takano M, et al. (2002) MyD88 is involved in the signalling pathway for Taxol-induced apoptosis and TNF-alpha expression in human myelomonocytic cells. Br J Haematol 118: 638-645.
34. Byrd-Leifer CA, Block EF, Takeda K, Akira S, Ding A, (2001) The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol. Eur J Immunol 31: 2448-2457.
35. Zimmer SM, Liu J, Clayton JL, Stephens DS, Snyder JP, (2008) Paclitaxel binding to human and murine MD-2. J Biol Chem 283: 27916-27926.
36. Pfannenstiel LW, Lam SS, Emens LA, Jaffee EM, Armstrong TD, (2010) Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in mice. Cell Immunol 263: 79-87.
37. Lee JJ, Swain SM, (2006) Peripheral neuropathy induced by microtubule-stabilizing agents. J Clin Oncol 24: 1633-1642.
38. Kobayashi N, Mundel P, (1998) A role of microtubules during the formation of cell processes in neuronal and non-neuronal cells. Cell Tissue Res 291: 163-174.
39. Cavaletti G, Tredici G, Braga M, Tazzari S, (1995) Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol. Exp Neurol 133: 64-72.
40. Jimenez-Andrade JM, Peters CM, Mejia NA, Ghilardi JR, Kuskowski MA, et al. (2006) Sensory neurons and their supporting cells located in the trigeminal, thoracic and lumbar ganglia differentially express markers of injury following intravenous administration of paclitaxel in the rat. Neurosci Lett 405: 62-67.
41. Risinger AL, Giles FJ, Mooberry SL, (2009) Microtubule dynamics as a target in oncology. Cancer Treat Rev 35: 255-261.
42. Letourneau PC, Ressler AH, (1984) Inhibition of neurite initiation and growth by taxol. J Cell Biol 98: 1355-1362.
43. Masurovsky EB, Peterson ER, Crain SM, Horwitz SB, (1983) Morphological alterations in dorsal root ganglion neurons and supporting cells of organotypic mouse spinal cord-ganglion cultures exposed to taxol. Neuroscience 10: 491-509.
44. Scuteri A, Nicolini G, Miloso M, Bossi M, Cavaletti G, et al. (2006) Paclitaxel toxicity in post-mitotic dorsal root ganglion (DRG) cells. Anticancer Res 26: 1065-1070.
45. Crume KP, Miller JH, La Flamme AC, (2007) Peloruside A, an antimitotic agent, specifically decreases tumor necrosis factor-alpha production by lipopolysaccharide-stimulated murine macrophages. Exp Biol Med (Maywood) 232: 607-613.
46. Cameron JS, Alexopoulou L, Sloane JA, DiBernardo AB, Ma Y, et al. (2007) Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals. J Neurosci 27: 13033-13041.
47. Shurin GV, Ouellette CE, Shurin MR, (2012) Regulatory dendritic cells in the tumor immunoenvironment. Cancer Immunol Immunother 61: 223-230.